In our production sites we mill a broad range of drug substances in multipurpose equipment with proven experience.
We are equipped with containment solutions (Glove- and Half Suit Boxes) to mill highly potent ingredients.
This product category can be processed thanks to dedicated micronization lines.
In our production sites, excipients are milled in GMP equipment. The food ingredients are processed in dedicated lines with the same standard we are used to apply to pharmaceuticals.
For more than 40 years, never ceasing to invest in research and in new contents on Micronization, in a much wider and integrated approach, has always been the sense of our job. Understanding and discerning evolving needs is a foremost task for a company providing services like ours.
we offer our expertise to develop robust processes through DoE studies.
We provide to our customers micronization and milling services with a deep experience in the particle size reduction.
The simultaneous micronization of at least two compounds improves powder properties and skip potential blending steps.
We are equipped with containment isolators, as part of a systematic approach to control the safe handling for potent compound.
With product conditioning we are able to resolve post micronization morphological issues.
Before the Process Validation activity, we support our customers with an approach to QbD by the identification of the Critical Process Parameters (CPP), to be studied during the following Design of Experiment (DoE) development step.
We provide to our customers particle size reduction by jet milling to very low temperature, for those compounds with a low brittleness and tacky, elastic polymers or semi-solid in nature. It is also used to prevent the degradation of highly sensitive products, to avoid polymorphic changes and to avoid any increase in amorphous particles.
We provide services for PSD analysis and related activities as method development, method validation, method transfer, etc. with our cutting-edge equipment.
Over time, our customers have requested newer and newer services depending on the market complexity. We have always worked embracing a concept of recognition and acceptance of Problem Solving, in a broad and factual sense. We have often been innovators in found and implemented solutions.
We guarantee a full confidentiality to our customers which rely on us as part of the development of new compounds.
The company, firmly in the hands of the founder’s second generation, continues along the path of complete independence able to ensure flexibility and avoid any conflict of interest towards its clients.
We ensure our customers having created a system of prevention and recovery from potential threats to the company.
We accompany our clients with expertise, supporting them with regular consulting services for each step of the projects.
We consider our expertise and experience as basic concept for a long-lasting partnership with our customers.
The milestones of our company philosophy are firmly pursued by the second generation and among them the guarantee of stability and business continuity. Elements that ensure flexibility, the respect of privacy and confidentiality of our whole profession.
We constantly improve the technology of our in-house designed mills which generates a precise scalability and maximizes the micronization yields
We provide a smart management of the projects evaluating the overall duration of the critical path in order to save time by accomplish customer´s needs.
We accommodate the needs of our customers adapting the day-to-day shifts with the willingness and ability to readily respond to changing circumstances and expectations.
We support our customers in their R&D process with our knowledge in particle size engeeneering
We have arranged a significant investment plan in our production sites that will entrain the doubling of our production and Micronization capacity. This decision was made to guarantee better and more performing lead times toward a market demanding such an expertise.
MUNIT has announced that it will soon participate in the following event: 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (11-14 May 2021) In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology …
MUNIT has announced that it will soon participate in the following event: Respiratory Drug Delivery 2021 (RDD 2021) Europe (04-07 May 2021) Respiratory Drug Delivery 2021 (RDD 2021) is the must attend, premier international conference for researchers, regulators, business professionals and suppliers active in pulmonary and nasal drug delivery. While the global pandemic is keeping …
MUNIT has announced that it will soon participate in the following events: 6th Annual Highly Potent Active Pharmaceutical Ingredients Online Summit (10-11 March 2021) This event will enable the participants to learn about the latest developments in the HPAPI Industry. This Summit will be focusing on latest market development trends in the highly potent active …
The 2021 Virtual Summit (15-17 March 2021) covers both small molecules and biologics, new technologies, concepts and case studies in areas such as: Formulation design for poorly soluble compounds The potential of nanotechnology for better deliverability The latest controlled released technologies Improving patient compliance by harnessing data and the latest smart device technology Optimising formulations …
Mr. Maurizio Schiavazzi
Chief Commercial Officer
Mr. Giovanni Frigerio
Chief Scientific Officer
Ms. Katia Zocca
Mr. Uwe Heidenreich
Business Development Manager
Mr. Massimo Dal Bosco
Business Development Manager
Via Crocicchio Cortogna 6
T. +41 (0)91 910 30 80